Home LiteratureArticle Details
PMID: 16574899 Published · ppublish English Comparative Study Journal Article Research Support, Non-U.S. Gov't

Hypercholesterolemia reduces collateral artery growth more dominantly than hyperglycemia or insulin resistance in mice.

Arteriosclerosis, thrombosis, and vascular biology ·Vol. 26 ·No. 6 ·2006-06-00 ·Pages 1383-90

van Weel V, de Vries M, Voshol PJ, Verloop RE, Eilers PH, van Hinsbergh VW, van Bockel JH, Quax PH

Abstract

Collateral artery development (arteriogenesis), a vital compensatory mechanism in patients with arterial obstructive disease, may be deregulated by vascular risk factors, eg, diabetes or hypercholesterolemia. Here, we compared the effects of either disturbed glucose metabolism or disturbed lipid metabolism on arteriogenesis. Femoral artery occlusion was performed in streptozotocin(STZ)-treated mice, nonobese diabetic (NOD) mice, and insulin-resistant Ob/Ob mice on regular diet, and APOE3*Leiden mice on different hypercholesterolemic diets. Angiography and laser Doppler perfusion analysis of hindlimbs were performed postoperatively. Surprisingly, angiographic arteriogenesis was not impaired in diabetic and insulin-resistant mice. Perfusion recovery in STZ-treated and Ob/Ob mice was only decreased by 19% and 16%, respectively (P<0.05). Furthermore, perfusion recovery was unchanged between high-glycemic and mild-glycemic NOD mice. Angiographic arteriogenesis in APOE3*Leiden mice, however, was markedly impaired at 7 days and 14 days (P< or =0.01). Correspondingly, perfusion recovery was 41% decreased in APOE3*Leiden mice (P<0.05). There was an inverse correlation of perfusion recovery with plasma cholesterol (P=0.02), but not with triglyceride, free fatty acid, glucose, or insulin levels. Hypercholesterolemia reduces arteriogenesis more dominantly than hyperglycemia or hyperinsulinemia in mice. This suggests that a disturbed lipid metabolism as observed in diabetic patients might be crucial for the impairment of collateral formation.

MeSH Terms
Acute Disease Animals Apolipoprotein E3 Apolipoproteins E/genetics Arteries/growth & development Blood Glucose/metabolism Cholesterol/blood Collateral Circulation Diabetes Mellitus, Experimental/blood,physiopathology Hindlimb/blood supply Hypercholesterolemia/blood,physiopathology Hyperglycemia/blood,physiopathology Hyperlipidemias/genetics,physiopathology Insulin/blood Insulin Resistance/physiology Ischemia/physiopathology Lipids/blood Male Mice Mice, Inbred Strains Neovascularization, Physiologic
Chemicals
Apolipoprotein E3 Apolipoproteins E Blood Glucose Insulin Lipids apolipoprotein E3 (Leidein) Cholesterol
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
van Weel Vincent
Gaubius Laboratory TNO Biomedical Research, Leiden, The Netherlands.
de Vries Margreet
Voshol Peter J
Verloop Robert E
Eilers Paul H C
van Hinsbergh Victor W M
van Bockel J Hajo
Quax Paul H A
Article Info
Journal
Arteriosclerosis, thrombosis, and vascular biology
Abbr.
Arterioscler Thromb Vasc Biol
ISSN
1524-4636
Published
2006-06-00
Epub
2006-00-30
Pages
1383-90
Language
English
Region
United States
NLM ID
9505803
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com